v3.26.1
Condensed Balance Sheets - USD ($)
Mar. 31, 2026
Dec. 31, 2025
ASSETS    
Deferred offering costs $ 429,263 $ 299,009
Total Assets 429,263 299,009
Current Liabilities    
Accrued offering costs 35,000 35,000
Promissory note - related party 498,079 307,760
Total Current Liabilities 533,079 342,760
Commitments and Contingencies  
Shareholder’s Deficit    
Preferred shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding  
Additional paid-in capital 24,384 24,384
Accumulated deficit (103,816) (43,751)
Subscription receivable (25,000) (25,000)
Total Shareholder’s Deficit (103,816) (43,751)
Total Liabilities and Shareholder’s Deficit 429,263 299,009
Common Class A [Member]    
Shareholder’s Deficit    
Common Stock Value  
Common Class B [Member]    
Shareholder’s Deficit    
Common Stock Value [1],[2] $ 616 $ 616 [3],[4]
[1] Includes an aggregate of 803,572 Class B ordinary Shares which will be surrendered to us for no consideration to the extent that the underwriters’ over-allotment is not exercised in full or in part.
[2] On May 12, 2026, our sponsor surrendered 6,160,714 founder shares to us for no consideration, which shares were cancelled, resulting in an aggregate of 6,160,715 founder shares outstanding. All shares and associated amounts have been retroactively restated to reflect the surrender (see Note 5).
[3] Includes an aggregate of 803,572 Class B ordinary Shares which will be surrendered to us for no consideration to the extent that the underwriters’ over-allotment is not exercised in full or in part.
[4] On May 12, 2026, our sponsor surrendered 6,160,714 founder shares to us for no consideration, which shares were cancelled, resulting in an aggregate of 6,160,715 founder shares outstanding. All shares and associated amounts have been retroactively restated to reflect the surrender (see Note 5).